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Effect of Dibutylnitrosamine and
Saccharin on Glutamyl Transpeptidasem
Positive Foci and Liver Cancer
by Michael A. Pereira,* Sydna L. Herren,*
and Alfred L. Brittt
An attempt was made to evaluate whether the simultaneous administration of the urinary bladder
tumor promoter, saccharin, and the substance being tested for carcinogenicity could be developed
into a rapid and efficient bioassay for bladder carcinogens. Dibutylnitrosamine (DBN) a bladder
and-to a lesser extent-liver carcinogen, was used as the test substance. The attempted evaluation
failed because of the high incidence of liver cancer in the rats that simultaneously received DBN
and saccharin. The simultaneous administration of 5% sodium saccharin in the diet and 0.02% DBN
in the drinking water of rats for 26 weeks resulted in an 81% DBN in the drinking water of male
rats for 26 weeks resulted in an 81% incidence of both hyperplastic nodules and hepatocellular car-
cinomas. A much lower incidence of 17 and 3% for hyperplastic nodules and hepatocellular carcino-
mas, respectively, was present in the rats that received only DBN, and no tumors were present in
the liver of rats that received only saccharin. The liver of the rats that received both DBN and sac-
charin compared to those that received only DBN also had an increased incidence of y-glutamyl-
transpeptidase (GGTase)-positive foci at 4, 8 and 26 weeks of treatment. The presence of GGTase ac-
tivity in hyperplastic nodules and hepatocellular carcinomas and the association of the increased in-
cidence of GGTase-positive foci with the increased incidence of tumors are consistent with a precur-
sor relationship of foci to hyperplastic nodules and hepatocellular carcinomas. Saccharin did not
increase the size of GGTase-positive foci, indicating that saccharin is not an hepatic tumor pro-
motor. The increased incidence of DBN initiated GGTase-positive foci and tumors that resulted from
the simultaneous administration for saccharin, implicates an hepatic cocarcinogenic activity for
saccharin.
Areas of GGTase-positive hepatocytes were induced in zone 1 by DBN, saccharin and DBN and
saccharin at 4 and 8 but not 26 weeks. These zonal areas of induced GGTase activity are different
from GGTase-positive foci. The induction of zonal GGTase activity by saccharin indicated that sac-
charin at the high dose of 5% in the diet can cause hepatotoxicity and/or bile ductule proliferation.
It is proposed that a regenerative response to the hepatotoxicity could result in an increased effi-
cacy of DBN initiation by increasing the fixation of DBN adduct in DNA.
Introduction
y-Glutamyltranspeptidase (GGTase)positive foci
are proposed to be preneoplastic lesions in rat livers
(1-3). The incidence of GGTase-positive foci has
been proposed to be associated with the extent of
the initiation of the neoplastic progression and with
the ultimate incidence of hyperplastic nodules and
hepatocellular carcinomas (1-3). The screening of
chemicals for tumor promoting and cocarcinogenic
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activity by demonstration of their ability to enhance
the incidence of GGTase-positive foci is predicated
on the capability of the incidence of foci to predict
the cancer incidence. A tumor promoter would act
after initiation to stimulate the growth of the foci so
that there is an earlier increase in foci and tumor in-
cidence. A cocarcinogen would act during initiation
to increase the efficacy of initiation as indicated by
an increased number of GGTase-positive foci.
Saccharin 1, 2-benzisothiazol-3(2H)one-1,1-dioxide,
(CAS No. 81-07-2) is a weak urinary bladder carcino-
gen in rats (1-4). Chemical carcinogenesis in the uri-
nary bladder has been divided into the two stages
of initiation and promotion. Sodium saccharin ad-PEREIRA, HERRENAND BRITT
ministered in the diet has been shown to promote
the incidence of urinary bladder cancer in rats that
were previously initiated with a subcarcinogenic
dose of either methylnitrosourea administered in-
travesically (4-6), FANFT, N445-nitro-2-furyl)2-thia-
zolylformamide administered in their diet (7) or N-
butyl-N44-hydroxybutyl)nitrosamine (BBN) in their
drinking water (8). In mouse skin (9,10) and urinary
bladder (8), tumor promoters have been shown also
to possess cocarcinogenic activity. The simultaneous
administration of the carcinogen and the promoter
resulted in an enhanced and more rapid appearance
of tumors than occurred in the two stage bioassay
consisting of the carcinogen followed by the
promoter. The study reported in this communica-
tion describes an attempt to develop a rapid and
efficient bioassay for bladder carcinogens that
consists ofadministering the substance being tested
for carcinogenicity simultaneously with the bladder
tumor promoter, saccharin. This communication also
describes the effect of saccharin concurrently ad-
ministered with dibutylnitrosamine (DBN) on the
relationship of DBN induced GGTase-positive foci to
hyperplastic nodules and hepatocellular carcinomas.
Materials and Methods
Chemicals
Sodium saccharin synthesized by the Maumee
Procedure was purchased from Sigma Chemical
Company (St. Louis, MO) and added at a concentra-
tion of 5% by weight to AIN-76 semipurified diet
purchased from ICN Nutritional Biochemicals
(Cleveland, OH). The sodium saccharin as expected
for Maumee synthesized saccharin, was determined
by gas chromatography to contain undetectable
levels of either o-toluenesulfonamide or p-toluene-
sulfonamide. Dibutylnitrosamine was purchased
from Eastman Kodak Company (Rochester, NY) and
N-y-L-glutamyl-4-methoxy-2-naphthylamide from
Bachem (Torrence, CA).
Animals
Male Fischer 344 rats were purchased from
Charles River Laboratories, Inc. (Portage, MI) and
were 7 to 8 weeks of age at the start of the experi-
ment. The animals were maintained in accordance
with the standards set forth in the literature (11).
They received their drinking water and food ad libi-
tum.
Experimental Design
The experimental design consisted of four treat-
ment groups. Group A received the control AIN-76
diet; Group B, AIN-76 diet and 0.02% DBN in their
drinking water; Group C, 5% sodium saccharin in
the AIN-76 diet; and Group D, 5% sodium saccharin
in the AIN-76 diet and 0.02% in their drinking
water. Rats were sacrificed from each of the four
groups at 4, 8, and 26 weeks of treatment. The ex-
periment was terminated at 26 weeks because of
the high mortality rate in Group D.
Histopathology
At the termination of the experiment, the rats
were killed by decapitation and necropsied. The uri-
nary bladder was inflated with 10% buffered forma-
lin and the inflated bladder and liver fixed in 10%
buffered formalin. After the tissues were embedded
in paraffin, sections obtained from each of four dif-
ferent lobes of the liver and a longitudinal section
from each of the two halves of the urinary bladder
were examined.
For evaluation of GGTase activity, tissues blocks
approximately 10 x 10 x 2 mm were taken from
three different lobes, rapidly frozen in optimum cut-
ting temperature (OCT) compound on dry ice and
stored at -800C for up to 6 months. Cryostat
sections (8 Mm) were mounted on slides, air-dried,
and stained for y-glutamyltranspeptidase activity ac-
cording to the method described by Rutenburg et
al. (12). Nuclei were counterstained with
hematoxylin. Only GGTase-positive foci of nine cells
(nuclei) or greater were scored. Figure 1 depicts a
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FIGURE 2. Average body weights of rats in the four treat-
ment groups from week 0 to 26 of the experiment: (x )
Group A, controls; (0) Group B, DBN; (+) Group C,
saccharin; (A) Group D, DBN and saccharin.
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typical GGTase-positive focus. The liver sections,
GGTase-positive foci and areas of GGTase-positive
hepatocytes were sized by projection of the image
onto the surface of a digitizer.
Results
Toxicity
The effect of treatment on the body weights of
the rats is presented in Figure 2. The rate of gain in
body weight over the course of the experiment was
not affected by DBN, but sodium saccharin caused a
decreased rate of gain. The body weight of the rats
that simultaneously received saccharin and DBN
were the lowest of all the groups and appeared to
decrease after 20 weeks, during which time a large
number of rats died. This high mortality rate in
Group D resulted in the termination of the experi-
ment at week 26.
The amount of drinking water consumed by the
rats of each group was determined on a biweekly
basis. Over the 26-week course of the experiment
the mean percentage ± standard error in drinking
water consumption determined as mL/100 mg body
weight relative to control (Group 4) was for Group B
97 ± 10, group C, 135 ± 10, and Group D, 134 ± 12.
The consumption of water by Group D was there-
fore on the average 37% greater than Group B.
The liver weights and their percentage of the
body weight are presented in Table 1. DBN did not
alter the percentage of the body weight repre-
sented by the liver, while sodium saccharin de-
creased the contribution of the liver to the body
weight. Upon histological evaluation, the livers from
the control and DBN treated rats contained hepato-
cytes with fat vacuoles that were diffusely dis-
persed, mainly in zone 1 of Rappaport. The livers
from saccharin-treated rats (Group C) lacked these
fat vacuoles which might explain their lower per-
cent of the body weight. The livers of the rats from
Group D represented an apparent, but not statisti-
cally significant, higher percentage of the body
weight. This apparent increase in the relative
weight of the liver probably resulted from the pres-
ence of the numerous large tumors. The rats in
Group D also had a complete lack ofbody fat.
FIGURE 1. GGTase-positive focus. The liver section was stained for y-glutamyltranspeptidase activity and counterstained with
hematoxylin. x 100.
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Initiation of GGTase-Positive Foci
The incidence of GGTase-positive foci was higher
in Group D when compared to Group A, B or C
(Table 2). At 26 weeks, Group B also had an in-
creased incidence of foci compared to Groups A or
C; however, throughout the course of the study the
incidence of foci in Group D was much greater than
Group B. At no time during the experiment did so-
dium saccharin administered by itself (Group C) sig-
nificantly increase the incidence of foci. Therefore,
DBN induced the formation of GGTase- positive foci
and the coadministration of saccharin greatly en-
hanced the response to DBN.
The size distribution of the GGTase-positive foci
was determined at 26 weeks for Group B and D
(Table 3). The size distribution of the foci was di-
vided into logarithmic intervals from 0.0-0.03 to >3
mm2. The foci in Groups B and D had the same size
distribution. Even the percentage of foci greater
than 3 mm2, which probably represents hyperplastic
nodules, was the same in Groups B and D. There-
fore, the concurrent administration of saccharin
with DBN did not increase the rate of growth of
GGTase-positive foci, so that saccharin did not ap-
pear to promote DBN hepatocarcinogenesis.
Tumorigenicity
Tumors were found only in the liver of rats from
Groups B and D (Fig. 3 and Table 2). The coadmini-
stration of sodium saccharin in the diet greatly in-
creased the incidence of hyperplastic nodules and
hepatocellular carcinomas that were induced by
DBN. The hyperplastic nodules and hepatocellular
carcinomas were positive for GGTase activity. The
carcinomas were of the trabecular type. In Group B,
animals which received only DBN, there were 16
Table 1. Body and liver weights at 26 weeks for the various experimental groups.
Liver weight,
Body Liver % of
Group Treatment Na weight, gb weight, gb body weight
A Control 11 391 ± 8.8 12.6 ± 0.85 3.21 ± 0.17
B DBN 29 367 ± 8.3 11.4 ± 0.41 3.10 ± 0.07
C Saccharin 36 337 ± 4.2 9.47 ± 0.21 2.81 ± 0.04*
D Saccharin 21 282 ± 10.7 10.7 ± 0.73 3.78 ± 0.20**
a N represents the number of animals at the termination of the study.
b Values are means ± SE.
* Different from Group A by the Student t test with p = 0.0017.
** Different from Group A by the Student t test with p = 0.085.
Table 2. Induction by DBN and saccharin of GGTase-positive foci and tumors in rat liver.
GGTase-positive foci/cm2 Hyperplastic nodules Carcinoma
Group Treatment 4 weeksa 8 weeksa 26 weeksa Animalsb % Animalsb %
A Control 0.43 ± 0.30(14) 1.63 ± 0.81(10) 0.31 ± 0.31(10) 0 0 0 0
B DBN 1.88 ± 0.45(12) 2.19 ± 0.72(8) 5.03 ± 1.06(29)* 5 17 1 3
C Saccharin 1.95 ± 0.61(13) 1.57 ± 0.54(9) 0.23 ± 0.23(36) 0 0 0 0
D DBN +
saccharin 6.26 ± 1.69(11)* + 9.19 ± 1.84(9)* + 31.31 ± 4.65(21)* + 17 81 17 81
a Foci results are mean ± standard error for the number of animals in parentheses.
b Results are the number of animals at 26 weeks with tumors among the animals observed for foci at 26 weeks.
* Results are different from Group A by the Student t test with p<0.01.
+ Results are different from Group B by the Student t test with p<0.01.
Table 3. Size distribution of GGTase-positive foci at 26 weeks.
Size distribution of GGT-ase positive foci, %
0.0-0.03 0.03-0.1 0.1-0.3 0.3-1 1-3 3
Group Treatment Na mm2 mm2 mm2 mm2 mm2 mm2
B. DBN 44 14c 41 30 9 5 2
D. DBN +
Saccharin 244 14 43 29 8 2 3
a N equals the number of foci evaluated.
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hyperplastic nodules among five of 29 (17%) rats
and two carcinomas in one of 29 (3%) rats, and in
Group D animals which received both DBN and sac-
charin, there were 106 hyperplastic nodules among
17 of 21 (81%) rats and 81 carcinomas among 17 of
21 (81%) rats. Therefore, DBN and not saccharin
possessed the ability to initiate tumors and the co-
administration of saccharin with DBN greatly en-
hanced the tumorigenic potency of DBN.
*~~~~~~~~~~~~~~~~~~~~.: :.: ... .... ...........
FIGURE 3. Liver from a rat simultaneously treated for 26
weeks with N-dibutylnitrosamine and saccharin (Group D)
that exhibited hyperplastic nodules and hepatocellular
carcinomas.
Urinary bladder tumors, either benign or malig-
nant, were not observed in any of the rats of the
four groups. There was simple focal/and/nodular-
papillary hyperplasia of the bladder transitional
epithelium in the animals that received either DBN
(Group B) or saccharin and DBN (Group D; Table 4).
The hyperplastic response was associated with the
administration of DBN and not the administration
of the sodium saccharin. The coadministration of so-
dium saccharin increased both the incidence and se-
verity of the hyperplastic response to DBN in the
urinary bladder.
Areas (Zone 1) of GGTase-Positive
Hepatocytes
During the course of this study, we observed an
induction in Groups B, C and D of GGTase activity
in hepatocytes in Zone 1 of the liver as defined by
Rappaport (Fig. 4). These zonal areas of GGTase-
positive hepatocytes were distinct from foci in that
they appeared to radiate out from most, if not all,
triads of a section, while foci were dispersed ran-
domly in all three zones. The percentage of the liver
containing GGTase activity in zone 1 hepatocytes is
presented in Table 5. At 4 and 8 weeks, an increase
in GGTase activity was observed in Groups B, C
and D. The order of efficacy was DBN + saccharin
> saccharin > DBN. The coadministration of DBN
and saccharin appeared to be synergistic, that is,
greater than the addition of the potencies of DBN
Table 4. Lesions of the urinary bladder.
Number of animals showing hyperplasiab
Simple Nodular and
Group Treatment Na Focal Papillary Total
A. Control 10 0 0 0
B. DBN 20 3(15) 4(20) 7(35)
C. Saccharin 25 1(4) 0 0
D. Saccharin + DBN 10 3(30) 4(40) 7(70)
a N represents the number of bladders examined by light microscopy. The remaining bladders were used for histochemical and
electron microscopic examination.
b Results are the number of animals examined that exhibited the lesions. Animals that exhibited both nodular and single focal
hyperplasia were scored for the more advanced nodular lesion. The numbers in parentheses are the percentage of the animals that
exhibited the lesion.
Table 5. Induction by DBN and saccharin of GGTase-positive hepatocytes.
GGTase-positive hepatocytes, % of livera
Group Treatment 4 weeks 8 weeks 26 weeks
A. Control 0.66 + 0.24(14)a 0.19 ± 0.10(10) 0 ± 0(10)
B. DBN 2.6 ± 0.53(12) 2.9 ± 0.73(9) 0.05 ± 0.03(29)
C. Saccharin 7.4 ± 1.4(13) 5.1 ± 1.2(9) 0 ± 0(36)
D. Saccharin + DBN 13.7 ± 1.4(11 16.3 ± 1.8(9) 0.92 ± 0.43(21)
a Results are means ± standard error for the number of animals in parentheses.
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FIGURE 4. Zonal areas of induced GGTase activity. The liver section was stained for GGTase activity and counterstained with
hematoxylin. The zonal areas of induced GGTase activity appear to radiate out from the triads. x 40.
and saccharin. Even in the presence of continuous
treatment with DBN and saccharin, by 26 weeks,
the zonal areas of GGTase activity had regressed.
GGTase-positive foci on the other hand, continued
to increase in number and size.
Discussion
The first step in the neoplastic progression of
chemical carcinogenesis is the initiation of the
target cell. Initiation is believed to start with the co-
valent binding of the carcinogen or one of its me-
tabolites to DNA. Replication of the DNA then com-
pletes the initiation step by fixation of the altera-
tion in the genetic code of the daughter strand.
DNA repair prior to fixation of the alteration pre-
vents initiation. Cellular replication of the geneti-
cally altered and initiated cell results in a focus of
cells expressing an altered phenotype. The acquisi-
tion of GGTase activity is one of the altered pheno-
types used to identify these foci of transformed he-
patocytes (1-3). The incidence of GGTase-positive
foci would, therefore, be an indication of the extent
to which a carcinogen has initiated carcinogenesis.
Dibutylnitrosamine induced GGTase-positive foci,
hyperplastic nodules and hepatocellular carcinomas.
The nodules and carcinomas also contained GTase
activity. When saccharin was administered concur-
rently with DBN, there was an increased incidence
of foci, nodules and carcinomas. This is consistent
with a precursor relationship of GGTase-positive
foci to hyperplastic nodules and hepatocellular carci-
nomas. Therefore, it appears that the induced inci-
dence of GGTase-positive foci by a chemical would
predict the hepatocarcinogenicity ofthe chemical.
Tumor promoters act after initiation has been
completed to stimulate the neoplastic progression
so that tumors appear earlier. The appearance of
GGTase-positive foci occurs at the end of the initia-
tion step so that the effect of promoters would be to
enhance the growth and progression of foci to can-
cer. The concurrent administration of saccharin
with DBN did not increase the size of GGTase-posi-
tive foci indicating that saccharin does not promote
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hepatocarcinogenesis. Ito et al. (13) have demon-
strated that saccharin is not a liver tumor promoter
inN-4-hydroxybutyl) nitrosamine-initiated rats.
One explanation for the enhancement of the inci-
dence of DBN induced GGTase-positive foci, hyper-
plastic nodules and hepatocellular carcinomas is
that the rats administered saccharin drank more
water and therefore received a larger dose of DBN.
Nakanishi et al. (8), in their cocarcinogenicity study
of saccharin with BBN, observed a similar 50% in-
crease in drinking water consumption in rats that
received saccharin with or without BBN in their
drinking water. It is unlikely, however, that the
37% increase in the dose of DBN as the result of
concurrent administration of saccharin would have
caused such a large (2600%) increase in hepatocellu-
lar carcinomas. Also, in rats, DBN is a much more
potent bladder carcinogen than liver carcinogen
(14-20). Therefore, if saccharin was acting solely to
increase the dosage of DBN, one would expect to
observe an increase in bladder cancer. We did not
detect any bladder tumors in the rats that received
concurrently DBN and saccharin. It would appear
that the effect of concurrently administered saccha-
rin to increase the carcinogenicity of DBN was
much greater in the liver than the bladder and
therefore was not simply the result of an increase in
dose. Other explanations of why saccharin was co-
carcinogenic toward DBN could be that saccharin
stimulated the hepatic uptake and metabolism of
DBN or induced an increase in cellular prolifera-
tion prior to the repair ofthe DBN adducts in DNA.
In support of the theory that a saccharin-induced
increase in cellular proliferation and fixation of
DBN adducts in DNA is the fact that saccharin in-
duced GGTase activity in the hepatocytes of zone 1.
These zonal areas of induced GGTase activity were
distinct from foci in their appearance, location in the
lobule, and regression by 26 weeks, even in the
presence of the inducer. Zonal induction of GGTase
activity is probably the source of the serum
GGTase activity used to indicate liver toxicity so
that, the high dose of 5% sodium saccharin in the
diet would appear to exert zone 1 toxicity in rat
liver. Zonal necrosis was observed in the liver in re-
sponse to saccharin by Chowaniec and Hicks (21). A
regenerative response to this necrosis could in-
crease the rate of cellular replication resulting in an
increased fixation of the DBN alteration in DNA.
This proposed increased fixation of the DBN altera-
tion in the DNA would result in an increased effi-
cacy of DBN initiation of GGTase-positive foci and
tumors.
The premature termination of the study due to
the high mortality in the rats that received both
DBN and saccharin occurred before the appearance
of DBN-induced urinary bladder tumors. DBN did
induce simple focal, nodular and papillary hyperpla-
sia and the concurrent administration of saccharin
increased both the incidence and severity of the le-
sions. The concurrent administration of sodium sac-
charin in the diet with N-butyl-N-4-hydroxybutyl)
nitrosamine (BBN) in the drinking water enhanced
the hyperplastic and tumor response to BBN (8). In
our investigation and Nakanishi's (8) study, the 37%
and 50% increase in drinking water consumption
resulting from saccharin administration obscured
the interpretation that saccharin is a cocarcinogen.
Therefore, further evaluation of the possible cocar-
cinogenic activity of saccharin is necessary.
Summary
Consistent with the proposed precursor relation-
ship of GGTase-positive foci to hepatocarcinogene-
sis, the induction of foci by DBN was associated
with the induction of hyperplastic nodules and hepa-
tocellular carcinoma and the concurrent administra-
tion of sodium saccharin in the diet with DBN in the
drinking water increased the tumorigenic response
in the liver to DBN.
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